Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Alphamab Co Ltd (9966 HK)
Watchlist
144
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Sichuan Biokin Pharmaceutical
•
24 Sep 2023 09:42
China Healthcare Weekly (Sep.22) - Medical Device VBP, Restore Optimism on Healthcare, Biokin Pharma
National VBP of intraocular lens/sports medicine medical consumables begins.Investors will maintain optimism when understand the logic behind...
Xinyao (Criss) Wang
Follow
795 Views
Share
bearish
•
Quantitative Analysis
•
30 Jul 2023 10:20
Hong Kong Connect Flows (Jul 28th): Kuaishou Technology, Tencent, HSBC
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Kuaishou Technology, Tencent, HSBC.
Ke Yan, CFA, FRM
Follow
467 Views
Share
bearish
•
Quantitative Analysis
•
16 Jul 2023 10:20
Hong Kong Connect Flows (Jul 14th): Meituan, BYD
We analyzed the Hong Kong Connect Scheme for last week. We estimate the outflows to be USD 38m and highlight flows for Meituan and BYD.
Ke Yan, CFA, FRM
Follow
468 Views
Share
bullish
•
Quantitative Analysis
•
09 Jul 2023 10:20
Hong Kong Connect Flows (Jul 7th): China Mobile, ICBC, ABC, Tencent, HSBC, BYD
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for China Mobile, ICBC, ABC, Tencent, HSBC, BYD.
Ke Yan, CFA, FRM
Follow
949 Views
Share
bearish
•
Quantitative Analysis
•
25 Jun 2023 10:15
Hong Kong Connect Flows (Jun 23rd): Tencent, Meituan, ICBC
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Meituan, Industrial And Commercial Bank Of China.
Ke Yan, CFA, FRM
Follow
630 Views
Share
First
Previous
11
12
13
14
15
16
17
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x